)
Visual
test
Global Health
Global Health (MEDANTA) investor relations material
Global Health Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary5 Feb, 2026
Executive summary
Q3 FY26 revenue grew 19% year-on-year to INR 11,428 million, driven by higher patient volumes, improved realization, and strong momentum across all hospitals.
EBITDA excluding Noida rose 10.9% year-on-year to INR 2,814 million (25.4% margin); including Noida, EBITDA was INR 2,494 million (21.8% margin) due to initial operating losses.
PAT was INR 950 million, impacted by higher depreciation, finance costs, and a one-time INR 366 million statutory labor code expense; adjusted PAT was INR 1,224 million.
144 beds were added in Q3, with significant expansion in Noida and Patna; Noida hospital completed its first full quarter, ramping up operations and adding 102 beds.
International patient revenue and OPD pharmacy business both grew over 30% year-on-year.
Financial highlights
Q3 FY26 total income: INR 11,428 million, up 19.1% year-on-year; consolidated profit after tax: INR 950 million (8.3% margin), adjusted PAT: INR 1,224 million (10.7% margin).
EBITDA (ex-Noida): INR 2,814 million (25.4% margin); EBITDA (incl. Noida): INR 2,494 million (21.8% margin); Noida generated INR 343 million revenue with an EBITDA loss of INR 320 million.
9M FY26 total income: INR 33,131 million, up 17.6% year-on-year; consolidated nine-month profit after tax: INR 4,124.15 million.
Mature hospitals revenue up 9.4% and EBITDA up 6.7% year-on-year; developing hospitals (ex-Noida) revenue up 21.5%, EBITDA up 13.3%.
Earnings per share (Q3): Standalone ₹2.97; Consolidated ₹3.54.
Outlook and guidance
Confident in steady improvement in Noida’s utilization and financial performance as ramp-up continues.
ARPOB growth projected at 5%-7% annually over the next 2-3 years, with single-digit growth expected as the new normal.
CapEx for FY27 expected below INR 500 crore, with major project outlays back-ended over the next 2-3 years; over INR 39,013 million capex planned over five years, funded by internal accruals and debt.
Focus on technology advancement, talent acquisition, and continuity of care to drive sustainable growth.
Company continues to monitor regulatory changes, especially regarding new Labour Codes, and will adjust accounting as needed.
Future Labour Code financial impact
Assam land development plans
Ms. Trehan's role in facility design strategy
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7 FebMGL
Strong revenue growth offset by lower margins and profit; interim dividend declared. - 7 FebPGIL
Strong revenue and margin growth, with India set for further expansion and upgraded ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights.
Next Global Health earnings date
Q4 25/2615 May, 2026
Global Health
Next Global Health earnings date
Q4 25/2615 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage